AVITA Medical, Inc. (RCEL) Presents at forty fourth Annual J.P. Morgan Healthcare Conference Transcript

Andrew Lang

Good afternoon, and thank you all for joining us this week at the JPMorgan Healthcare Conference. My name is Andrew Lang and I’m an associate here on the JPMorgan Healthcare Investment Banking team. It is my pleasure to introduce AVITA Medical and its CEO, Cary Vance. We’ll have a short Q&A session afterwards. But Cary, turn it over to you.

Cary Vance
Independent Non-Executive Chairman & Interim CEO

Thank you, Andrew. Good to be with you all this afternoon. I’ve been involved with AVITA Medical for about 3 years. I joined the Board 3 years ago and then became CEO 3 months ago. So the reason why I joined the Board, the reason why I love being a part of AVITA is the mission that AVITA has. We’re all about patient care. We’re a patient-centric customer-centric organization. I think you’ll see some of that. I’ve been involved in a lot of different companies where we try to change health care and bring new standards of care to patients. In order to do that, we really need to check a few boxes. One is, obviously, clinical data, clinically driven innovation. Logistically, workflow-wise, it needs to work for our customers. And then ultimately, there needs to be an economic benefit to them as well. And so I think we tick all those boxes, you’ll see that as we go through the presentation.

Our customers and our patients depend on us in their worst times. We usually care for patients on their worst days. And that’s illustrated. We are just dipping our toes in the water in Europe in